Patents Assigned to DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., LTD.
  • THIOPHENE DERIVATIVES AS XANTHINE OXIDASE INHIBITORS AND APPLICATION THEREOF
    Publication number: 20230322703
    Abstract: A class of xanthine oxidase (XO) inhibitors, and application thereof in the preparation of drugs for treating XO-related diseases. Specifically disclosed is a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 30, 2020
    Publication date: October 12, 2023
    Applicants: DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., LTD., MEDSHINE DISCOVERY INC.
    Inventors: Yang ZHANG, Wentao WU, Wenyuan ZHU, Shuhui CHEN
  • SGLTS/DPP4 INHIBITOR AND APPLICATION THEREOF
    Publication number: 20220259247
    Abstract: A class of compounds as a SGLT1/SGLT2/DPP4 triple inhibitor, and an application in preparation of a drug serving as the SGLT1/SGLT2/DPP4 triple inhibitor. Compounds represented by formula (I), and isomers and pharmaceutically-acceptable salts thereof are specifically involved.
    Type: Application
    Filed: July 24, 2020
    Publication date: August 18, 2022
    Applicant: DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., LTD.
    Inventors: Qinghua MAO, Tao YU, Yi LI, Chengde WU, Shuhui CHEN